Atlas Trials

IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney Transplantation (TASMANIA)

Clinical trial NCT04832841 · COMPLETED

Trial details

NCT number
NCT04832841
Sponsor
Institute for Clinical and Experimental Medicine
Status
COMPLETED
Study type
OBSERVATIONAL
Kidney Transplantation
Start date
2021-03-18
Primary completion
2021-09-30
Enrollment
753

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.